Cepharanthine inhibits tick‑borne encephalitis virus infection through modulation of the stress and inflammation response

The study by Tang and Zhao (2026) demonstrates that Cepharanthine effectively inhibits tick-borne encephalitis virus (TBEV) infection by modulating the body's stress and inflammation responses. The research highlights Cepharanthine's potential as a therapeutic agent against TBEV, emphasizing its role in altering cellular pathways related to stress and inflammation, which are crucial in the virus's life cycle. This finding suggests a promising avenue for developing treatments for TBEV infections.